Abilify Approved for Adolescents with Schizophrenia
Posted on November 7, 2007 by cherished79
Sanctioned for adults in 2002
By Scott Roberts
TUESDAY, Nov. 6, 2007 (HealthDay News) — The U.S. Food and Drug Administration has approved the Bristol-Myers Squibb antipsychotic drug Abilify (aripiprazole) for adolescents aged 13 to 17 diagnosed with schizophrenia, the company said Tuesday.
The FDA first approved the drug to treat schizophrenia in adults in November 2002. More [...]
Filed under: FDA, adolescent, bipolar disorder, health, mania, medications, mental illness, schizophrenia | No Comments »
